- Previous Close
0.0088 - Open
0.0090 - Bid 0.0084 x --
- Ask 0.0092 x --
- Day's Range
0.0084 - 0.0092 - 52 Week Range
0.0062 - 0.2090 - Volume
5,528,566 - Avg. Volume
14,118,318 - Market Cap (intraday)
12.344M - Beta (5Y Monthly) -0.37
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Spermosens AB provides diagnostic health care products and services in Sweden. The company offers male infertility fertility diagnostics and fertility treatments for the IVF market. It develops JUNO-Checked, a device that measures the binding between sperm and egg cell to enable individualized choice of fertility treatment based on measured binding. Spermosens AB was incorporated in 2018 and is based in Lund, Sweden.
www.spermosens.com3
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SPERM.ST
View MorePerformance Overview: SPERM.ST
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SPERM.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SPERM.ST
View MoreValuation Measures
Market Cap
12.34M
Enterprise Value
11.91M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.45
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-20.04%
Return on Equity (ttm)
-50.97%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-10.2M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
659k
Total Debt/Equity (mrq)
0.84%
Levered Free Cash Flow (ttm)
-12.55M